Evidence map›Paper›PMID 19740104›Full record

ArticleThe FEBS journal2009

Mutational analysis of the preferential binding of human topoisomerase I to supercoiled DNA.

Zheng Yang, James F Carey, James J Champoux

Abstract read
In one paragraph

Article in The FEBS journal, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zheng YangDepartment of Microbiology, School of Medicine, University of Washington, Seattle, WA 98195-7242, USA.
James F Carey
James J Champoux

Funding

EUKARYOTIC TOPOISOMERASE IR01GM049156 · NIGMS · UNIVERSITY OF WASHINGTON · PI CHAMPOUX, JAMES J · 1994 to 2010
$2.9M
DNA BINDING BY HUMAN TOPOISOMERASE IR01GM060330 · NIGMS · UNIVERSITY OF WASHINGTON · PI CHAMPOUX, JAMES J · 2000 to 2003
$949k
NIGMS NIH HHS GM49156NIGMS NIH HHS GM60330NIGMS NIH HHS R01 GM049156NIGMS NIH HHS R01 GM060330
6 · The paper itself

Abstract

Human topoisomerase I binds DNA in a topology-dependent fashion with a strong preference for supercoiled DNAs of either sign over relaxed circular DNA. One hypothesis to account for this preference is that a second DNA-binding site exists on the enzyme that mediates an association with the nodes present in supercoiled DNA. The failure of the enzyme to dimerize, even in the presence of DNA, appears to rule out the hypothesis that two binding sites are generated by dimerization of the protein. A series of mutant protein constructs was generated to test the hypotheses that the homeodomain-like core subdomain II (residues 233-319) provides a second DNA-binding site, or that the linker or basic residues in core subdomain III are involved in the preferential binding to supercoiled DNAs. When putative DNA contact points within core subdomain II were altered or the domain was removed altogether, there was no effect on the ability of the enzyme to recognize supercoiled DNA, as measured by both a gel shift assay and a competition binding assay. However, the preference for supercoils was noticeably reduced for a form of the enzyme lacking the coiled-coil linker region or when pairs of lysines were changed to glutamic acids in core subdomain III. The results obtained implicate the linker and solvent-exposed basic residues in core subdomain III in the preferential binding of human topoisomerase I to supercoiled DNA.

Indexed as

DNA Mutational AnalysisDNA, SuperhelicalDNA Topoisomerases, Type IElectrophoretic Mobility Shift AssayHumansModels, MolecularMutationNucleic Acid ConformationProtein BindingProtein MultimerizationProtein Structure, SecondaryDNA, SuperhelicalDNA Topoisomerases, Type I

Identifiers

PMID19740104
PMCPMC3107988

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.